Login or Register to book onto an event:
- 3 May 2017
- 18:00 - 20:00
- Mereview Restaurant, Alderley Park
Member ticket: FREE
Non member ticket: £10.00
Corporate employer ticket: FREE
Corporate member ticket: FREE
North West branch
AstraZeneca’s transformational relocation to Cambridge – the story so far
Four years ago, AstraZeneca took a momentous decision to relocate its scientific workforce from its R&D facility in the North West and its head office in London to a new facility in the East of England. The goal was to reshape AstraZeneca’s science footprint to drive innovation and pipeline productivity by concentrating on three strategic locations in the US, Sweden and the UK.
A new purpose-built facility in Cambridge is designed to be a 'great place to work', supporting a culture that is science-led and patient-focused, agile and high-performing, which retains and attracts great people. Four years on and the company has achieved its target of 2,000 employees in Cambridge and has created a new, vibrant science community in Alderley Park.
Mike Cadman, Programme Manager for the UK Footprint and Graeme Bristow, AZ Alderley Park Site Leader will be sharing the two halves of the journey.
They will be looking back to the beginning of this journey, when the strategic vision was first articulated, the individual impact that it had, and how the programme ensured that the company continued to deliver its pipeline and how Alderley Park's future was secured as a vibrant centre for life sciences.
They will also be looking forward to the changes that are still to come, how to get people to operate in the new world of internal and external collaboration.
The seminar’s ‘game of two halves’ will be interspersed with break out sessions during which delegates will have the opportunity to reflect on and share their own experiences of organisational and strategic change.This event was successfully run in Cambridge with support from Elisabeth Goodman, Enabling Change SIG Volunteer.
Mike Cadman is the Programme Director for the AstraZeneca UK Footprint Programme, a programme responsible for relocating R&D functions from Alderley Park and the company head office from London, into a new purpose built facility in Cambridge.
Mike is a PhD chemist by training and is an accredited project and programme manager with a broad interest in 3P. He is particularly interested in the successful delivery of change in complex projects and programmes. Mike has 30 years of experience working in the chemical and pharmaceutical industries. Initially working in technology and manufacturing he then moved into broader supply chain roles. Mike also has many years of experience as a line manager delivering organisational changes and has worked as a risk manager.
Graeme Bristow is the Alderley Park Site Leader. Graeme has worked in the pharmaceutical industry for 25 years. In this time he has worked in site leadership, manufacturing and R&D across the UK and also in the US. He has brought forward over 20 cancer and antiviral drug development programmes, many in alliance with other pharmaceutical companies. He is the co-creator and founder of the BioHUB, a highly successful bioscience incubator based in the UK.
Graeme earned his Master’s Degree in Engineering from Sheffield University and his Masters in Pharmaceutical Science from UMIST (University of Manchester). In 2003, he was appointed a Fellow of the Institute of Mechanical Engineering.
This event is run in collaboration with the Institution of Chemical Engineers (IChemE).
This event is suitable for professionals with any level of experience.
APM Body of Knowledge reference